Background: The choice between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) remains controversial.
Introduction
Percutaneous coronary intervention (PCI or angioplasty) and coronary artery bypass grafting (surgery or CABG) are well-accepted, safe, and effective alternatives in the treatment of coronary insufficiency. A large number of randomized clinical trials has been published comparing both procedures. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] In light of these studies, there seems to be a slight superiority of surgery over PCI in the ability to reduce anginal symptoms and a significant difference in its ability to prevent new revascularization procedures. Such studies are generally undersized to evaluate outcomes like death, stroke, and acute myocardial infarction (AMI).
The objective of this study was to perform a meta-analysis of randomized clinical trials comparing PCI and CABG in multivessel disease and obstruction of the left main coronary artery in the era of drug-eluting stents, with emphasis on mortality and stroke.
Methods
Randomized studies comparing PCI with drug-eluting Original Article references of reviews published on the subject. The date of January 2002 was chosen as the initial period since drug-eluting stents began to be established as a therapeutic method after that. Clinical trials were included in the review if they were randomized, had compared surgery and coronary angioplasty, used drug-eluting stents, involved exclusively multivessel disease or left main coronary artery obstruction, had a minimum follow-up of 1 year, and were published in international journals with an impact factor > 2.0. We used the following terms in the search: coronary artery bypass surgery, coronary stents, and randomized controlled trials. Studies exclusively using balloon or bare-metal stents, or which assessed predominantly one-vessel disease were not included. Studies using drug-eluting and bare-metal stents 1, 4 were included as studies of the drug-eluting stent era. Works resulting from observational studies (registries) or only published as meetings proceedings were not considered.
We identified 10 randomized studies that satisfied the requirements: LE MANS, 1 SYNTAX, 2-3 CARDia, 4 Boudriot et al., 5 PRECOMBAT, 6 VA CARDS, 7 FREEDOM, 8 BEST, 9 NOBLE, 10 and EXCEL. 11 Three authors (PJNA, BAAF, and JLAAF) evaluated the studies, which were all considered to be of high quality.
The main outcomes of interest were mortality and stroke. The incidence of AMI was not evaluated because the definition of this event varied widely in the studies. We also did not evaluate the incidence of new revascularization, because the superiority of surgery on this outcome is well established. Mortality was divided into early mortality, mortality at 1 year, and late mortality. Early mortality was defined as death occurring up to 30 days after the procedure, including deaths occurring after randomization but before the procedure. This mortality was obtained from seven studies, whereas three studies did not provide this information. 2, 4, 7 Mortality at 1 year was defined as death occurring up to 1 year after the procedure, including early mortality. This mortality was obtained from nine studies, while one study did not provide such information. 9 Late mortality was defined as death recorded at the end of follow-up, after at least 3 years. This mortality was obtained from eight studies, six of which performed a follow-up for 5 years, one for 3 years 2 and one for 10 years. 1 We were unable to obtain this information from two studies. 5, 7 For the incidence of stroke, we considered the events occurring up to 1 year after the procedure. In eight studies, we obtained the results up to 30 days and in one of them, 2 up to 1 year, while in one of the studies, this information was unavailable. 9 We evaluated separately the results of studies in the left main coronary artery and late mortality in the subgroup of patients with diabetes.
We also performed analysis of combined major adverse cardiac and cerebrovascular events (MACCE) and assessed the variables age, gender, presence of diabetes, SYNTAX score, and compromised ejection fraction in subgroups based on data published in five trials. 2, 4, 6, 8, 9 Combined MACCE comprised death, AMI, and new revascularization in two of these trials, 6, 9 and death, AMI, and stroke in the remaining ones.
In order to aggregate the outcomes of mortality and stroke, as well as those of MACCE (in subgroups), we considered whenever possible the absolute number of events and the number of patients followed up. Otherwise, percentages were transformed into absolute numbers.
Statistical analysis
We measured the relative risk and the risk difference after grouping the results of each outcome. In order to assess the statistical significance of the differences between the drug-eluting stent and the surgery groups, we performed a meta-analysis using the Mantel-Haenszel method, with a fixed-effect model. We calculated the heterogeneity of the studies using Cochran's Q test and the significance of the measure of the meta-analytic effect using the Z test.
The differences between the results in the stent and CABG groups were considered significant if p < 0.05.
The statistical analyses were performed using the In order to represent the heterogeneity of the studies, we constructed Forest plots. We used the risk difference to plot these graphs since this is a more stable index. We refrained from using odds ratio or relative risk due to the inclusion of some clinical trials with zero or near zero events.
Results

Characteristics of the trials are shown in table 1
The studies included a total of 9268 patients (4642 in the stent group and 4626 in the CABG group). The mean age of the patients was 64 years, 75% were male, 51%
were diabetic, 24% were smokers, 64% were hypertensive, and 31% had unstable angina. The mean ejection fraction (reported in seven studies) was 59%, the mean EuroSCORE (reported in five studies) was 2.9, and the mean SYNTAX 
Outcomes
The outcomes are summarized in Figures 1 to 6.
The incidence of stroke up to 1 year had a low heterogeneity (I 2 = 0). The results favored PCI (0.4% versus 1.5%, p < 0.00001). In regards to 30-day mortality, the studies showed low heterogeneity (I 2 = 0) and favored the stent group (0.8% versus 1.5%, p = 0.005). As for mortality up to 1 year, the studies presented low heterogeneity (I 2 = 0%) and no difference between the groups (3.4% versus 3.5%, p = 0.50). In late mortality, the studies showed low heterogeneity (I 2 = 0%) and favored CABG ( ). In the combined results (n = 3223), mortality up to 5 years was 12.5%
in the stent group versus 9.7% in the surgery group (p < 0.0001).
Five studies provided the outcomes of the late incidence of combined adverse events (MACCE) divided into subgroups, which are represented in Figure 7 . The combined MACCE outcomes in these subgroups ( Figure 7) show that a SYNTAX 
Discussion
Several systematic reviews, collaborative studies, and meta-analyses [13] [14] [15] [16] [17] [18] have been published comparing PCI and CABG. The most important ones included studies of the balloon and bare-metal stent era or left out important recent studies. [14] [15] [16] The main differential of the present meta-analysis is the large number of included studies and patients and the fact that it is up-to-date and included only trials of the drug-eluting stent era. In the evaluation of the results, it is important to highlight the superiority of PCI in the mortality at 30 days. This is in line with a prior systematic review 17 and with the New York registry. 19 The difference is obviously not applicable to patients with lesions of high angiographic complexity, as seen in the analysis of the survival curves of aggregated results from SYNTAX LM and PRECOMBAT. 20 A greater incidence of stroke in the surgical group had already been suggested in prior systematic reviews, 14, 17 and in the light of the data presented here, this fact becomes indisputable. It is worth mentioning a reduced incidence of stroke in more recent studies, reflecting a greater care taken by surgeons while manipulating the aorta. The similarity of the mortality results at 1 year is aligned with a prior systematic review, which included studies of the era prior to drug-eluting stents. 17 The difference favoring surgery in regards to late mortality is consistent with another meta-analysis 16 and also with a recently published collaborative study. 21 It should be emphasized that the difference found was due to the large number of patients with diabetes in the studies of the drugeluting stent era, which disappeared in the aggregated results when these studies were excluded. These data confirm those of the collaborative study by Hlatki et al. 15 , which demonstrated a lower overall mortality at 5 years with surgery, but no difference among nondiabetic patients. We should emphasize that the study by Hlatki et al. 15 Despite that, the American guidelines only changed the recommendation to IIA in patients with a low SYNTAX score and IIB in patients with intermediate SYNTAX scores. 18 We should emphasize that such recommendations are restricted to patients with a high surgical risk. In the present study, which combined the results of six studies with 4700 patients, the outcomes of PCI with drug-eluting stents were equal or even greater than those with CABG. In light of these evidence and recent results of NOBLE and EXCEL, we believe that the American and Brazilian guidelines 22, 23 may be soon modified to improve the classification of PCI with drug-eluting stents, mainly in left main coronary artery obstruction.
In relation to the results in patients with diabetes, it is important to remember that the evidence contrary to PCI in diabetes has its origin in the balloon era, from occasional The MACCE outcomes in subgroups (Figure 7) in the present study demonstrate that the SYNTAX score in the upper tertile strongly and negatively influenced the PCI outcomes, similarly to the presence of diabetes. The elderly condition and the female gender had a small influence on the results; an ejection fraction < 50% did not negatively influence the PCI outcomes, but an ejection fraction < 35% had a greater impact, even though it had no statistical significance. These results are in agreement with those of the collaborative study by Cavalcante et al. 20 In that study, 
Study limitations
This study has important limitations. Because the meta-analysis included published data rather than individual patient data, we were unable to analyze the mortality outcomes in subgroups, except in those with diabetes.
Additionally, the percentages had to be processed as absolute numbers, which may deserve criticism. The results apply only to patients in whom revascularization is possible by both methods and without a high surgical risk or history of prior surgical revascularization, and with the procedures carried out in institutions of excellence.
Conclusion
In combined results of randomized studies involving 
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